ACTICOAT* Silver-Coated Antimicrobial Barrier Dressings are used to manage wounds by providing broad-spectrum bactericidal activity against over 150 pathogens in 30 minutes.
• Proprietary silver technology
• Broad-spectrum antimicrobial activity against over 150 organisms including 200 strains of MRSA and 5 organisms that carry the NDM-1 enzyme (in vitro)
• Three day wear time
• Provides bactericidal activity within 30 minutes
• May help reduce the risk of infection
• Can be used on extensive body surface area wounds and over debrided wounds
• Can be cut to size
ACTICOAT* is indicated for use on partial- and full-thickness wounds, such as pressure injuries, diabetic ulcers, venous ulcers, surgical sites, donor sites, grafts/dermal substitutes, and first- and second-degree burns.
Do not use on patients with a known sensitivity to silver. During MRI (Magnetic Resonance Imaging) examination, remove from area within the anatomical field being imaged.
Prior to administering radiation therapy, remove ACTICOAT*. A new dressing can be applied following treatment.
Do not use if product color is not uniform.
For external use only.
ACTICOAT* is not compatible with oil-based products, such as petrolatum.
Avoid contact with electrodes or conductive gels during electronic measurements (eg, EEG and ECG).
ACTICOAT* should only be used on premature infants (less than 37 weeks gestation) when the clinical benefit outweighs potential risks. No clinical data is available on this age group and only limited data is available for use on neonates.
ACTICOAT* is not intended to provide sole treatment for infected wounds.
ACTICOAT* may be used on infected wounds which are being managed per local clinical protocol.
May cause transient discoloring of surrounding skin.
Avoid exposure to temperatures above 120°F (50°C). Protect from light.
|Absorptive dressing format|
|Alginate dressing format|
|Antimicrobial effects up to 48 hours|
|Antimicrobial effects up to 3 days||●|
|Antimicrobial effects up to 7 days|
|Collagen dressing format|
|Composite dressing format|
|Contact layer dressing format||●|
|Foam dressing format|
|Gauze or non-woven dressing format|
|Gelling fiber dressing format|
|Hydrogel (amorphous) dressing format|
|Hydrogel (impregnated) dressing format|
|Hydrogel (sheet) dressing format|
|Impermeable to outside contaminants|
|Impregnated dressing format|
|Moisture vapor permeable|
|Secondary dressing required||●|
|Super absorbent polymers|
|Sustained release formula||●|
|Transparent film dressing format|
|Wound filler dressing format|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
First- and Second-Degree Burns
Grafts and Donor Sites
Moderately/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Follow standard protocol to cleanse wound; do not use saline or oil-based cleansing agents.
For heavily exudative wounds:
Remove the ACTICOAT* Dressing from the package and cut to size. Apply the dry ACTICOAT* Dressing to the wound, either side down, as the exudate will be sufficient to activate the dressing. Cover the ACTICOAT* Dressing with an appropriate secondary dressing.
For other wounds:
Remove the dressing from package and cut to shape. Moisten the dressing with sterile water (do not use saline). Allow the dressing to drain on an absorbent surface in a sterile field for at least 2 minutes. Apply the ACTICOAT* Dressing to the wound surface, either side down.
Cover the dressing with an appropriate secondary dressing.
If the dressing dries and adheres to the wound, moisten or soak the dressing prior to removal. Avoid forceful removal of the dressing and disruption of the healing wound.
For detailed product information, including indications for use, contraindications, precautions, and warnings, please consult the product's Instructions for Use (IFU) prior to use.
Change the dressing depending on the amount of exudate and the condition of the wound, or every 3 days.
ACTICOAT* Dressings can be used under compression therapy. Regularly check dressing system and change if strikethrough occurs.
For over 150 years, Smith+Nephew has taken a pioneering approach to product design and services, helping to reduce the human and economic costs of wounds.
Advanced Wound Bioactives
(Includes Collagenase SANTYL* Ointment, PROSHIELD* Foam & Spray Incontinent & Total Body Cleanser, PROSHIELD* Plus Skin Protectant, REGRANEX* (becaplermin) Gel 0.01%)
Toll-free: (800) 441-8227
Fax: (817) 900-4100
Cellular and/or Tissue-Based Products
(Includes GRAFIX PL*, GRAFIX*, STRAVIX*, OASIS® MICRO, OASIS® Wound Matrix, OASIS® Burn Matrix, and OASIS® Ultra Tri-Layer Matrix)
Phone: (888) 674-9551
Fax: (443) 283-4419
Advanced Wound Care or Devices
(PICO* Single Use Negative Pressure Wound Therapy, RENASYS* TOUCH Negative Pressure Wound Therapy, RENASYS* GO Negative Pressure Wound Therapy)
Toll-free: (800) 876-1261
Fax: (727) 392-6914
*Trademark of Smith+Nephew